Mr. Toobin is a contributing Opinion writer and the author of “The Pardon: The Politics of Presidential Mercy.” The effort by the Trump administration to penalize major law firms descended into black ...
The Green Bay Packers made the postseason for the third consecutive season. Green Bay was one of six NFL teams to make the playoffs in each of the last three seasons (2023-25), joining Buffalo, ...
Turns out there won’t be a big trademark lawsuit between Edsel Dope and Rock & Roll Hall of Famers Chuck D and The Doors drummer John Densmore over the use of the name doPE for their side project, as ...
Ridley Scott is best known for his work directing massive sci-fi epics like Alien and Blade Runner, but last year he worked on a more grounded Apple TV series that’s returned to streaming charts.
Dope frontman Edsel Dope has made a public plea online with Public Enemy's Chuck D and The Doors' John Densmore over a new band they formed name doPE. The rapper and drummer just announced the project ...
Last week, Chuck D and John Densmore announced their debut album no country for old men under the name of doPE. The moniker is meant to combine the beginning of the Doors' lowercase logo and the ...
Back in 2014, when Chuck D was the official ambassador for Record Store Day, the Public Enemy firebrand met Doors drummer John Densmore on an RSD panel. As the story goes, a year later Chuck emailed ...
*John Densmore of The Doors and hip-hop legend Chuck D of Public Enemy have teamed up for a new musical project called doPE. Their debut album, “no country for old men,” combines spoken word, rhythm, ...
Dope House Records celebrates 30 years of independence with If Animals Could Talk, a 30-track Christmas Day release from SPM that reinforces the label’s legacy of ownership, storytelling, and cultural ...
Dope Shows co-founder Jamir Shaw still remembers the longest non-pandemic pause of his concert promotion career — a moment that, ironically, felt like a vocational curtain call. One year after leaving ...
The pot industry -- Big Dope -- is heavily invested in getting its product recategorized from a Schedule 1 to a Schedule 3 drug, writes columnist Daniel McCarthy. Helayne Seidman Will more marijuana ...